Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2915-2926
Author(s):
Adelaide Fernandes and Dora Brites
Translocator Protein Ligands as Promising Therapeutic Tools for Anxiety Disorders
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3359-3380
Author(s):
S. Taliani, F. Da Settimo, E. Da Pozzo, B. Chelli and C. Martini
Mining the Genome for Susceptibility to Complex Neurological Disorders
Journal:
Current Molecular Medicine
Volume:
9
Page:
801-813
Author(s):
A. K. Gubitz and K. Gwinn
Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?
Journal:
Current Drug Targets
Volume:
10
Page:
842-849
Author(s):
Y. Kadoi and S. Saito
Editorial [Hot Topic: Adenosine-Based Modulation of Brain Activity (Guest Editor: DETLEV BOISON)]
Journal:
Current Neuropharmacology
Volume:
7
Page:
158-159
Author(s):
Detlev Boison
Release of Adenosine and ATP During Ischemia and Epilepsy
Journal:
Current Neuropharmacology
Volume:
7
Page:
160-179
Author(s):
Nicholas Dale and Bruno G. Frenguelli
Tuning and Fine-Tuning of Synapses with Adenosine
Journal:
Current Neuropharmacology
Volume:
7
Page:
180-194
Author(s):
A. M. Sebastiao and J. A. Ribeiro
Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Journal:
Current Neuropharmacology
Volume:
7
Page:
195-206
Author(s):
Hai-Ying Shen and Jiang-Fan Chen
The Role of Adenosine in Alzheimers Disease
Journal:
Current Neuropharmacology
Volume:
7
Page:
207-216
Author(s):
Anisur Rahman
Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant
Journal:
Current Neuropharmacology
Volume:
7
Page:
217-227
Author(s):
Rebecca L. Williams-Karnesky and Mary P. Stenzel-Poore